Skip to search formSkip to main contentSkip to account menu

ATX-101

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
ATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR.
BACKGROUND Submental fat (SMF) can negatively affect perceptions of health and attractiveness. The Condition of Submental… 
2018
2018
Improvements in submental fat achieved with the use of ATX-101 (deoxycholic acid injection) are maintained over time: Three-year follow-up data from the phase 3 REFINE trials
2018
2018
Commentary on: Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
2017
2017
Abstract: Injection Adipocytolysis with ATX-101 (Deoxycholic Acid) for Body Contouring
INTRODUCTION: Deoxycholic acid currently approved only for minimally invasive treatment of submental fat. The effects of… 
2017
2017
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat: ERRATUM.
I read with interest the article by Jeff Dover and colleagues in the November Special Issue of Dermatologic Surgery. Sodium… 
2016
2016
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.
Review
2015
Review
2015
[The use of deoxycholic acid (ATX-101) in aesthetic medicine: A promising treatment].
2015
2015
L’utilisation de l’acide désoxycholique (ATX-101) en médecine esthétique : un traitement prometteur
2013
2013
A Multicenter, Randomized, Double-Blind Phase 2B Study of ATX-101 in the Reduction of Submental Fat Using Investigator, Subject, and Magnetic Resonance Imaging Assessments
2012
2012
ATX-101 Nearing End of Development Pipeline
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)